Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma (Q39974620)

16 September 2017

title

Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma (English)

1 reference

16 September 2017

0 references

V Roh

1

1 reference

16 September 2017

A Laemmle

2

1 reference

16 September 2017

U Von Holzen

3

1 reference

16 September 2017

D Stroka

4

1 reference

16 September 2017

J-F Dufour

5

1 reference

16 September 2017

K K Hunt

6

1 reference

16 September 2017

D Candinas

7

1 reference

16 September 2017

S A Vorburger

8

1 reference

16 September 2017

publication date

6 June 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

15

1 reference

16 September 2017

issue

10

1 reference

16 September 2017

page(s)

636-644

1 reference

The yin and yang of E2F-1: balancing life and death

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

21 January 2018

E2F-1 induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Role for the p53 homologue p73 in E2F-1-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Loss of PKR activity in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

The double stranded RNA-activated protein kinase induced by interferon: dsRNA-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Hepatocellular carcinoma and hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin potentiates the radiation response of tumor cells grown as monolayer cultures and spheroids by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Interferon-alpha inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Stereospecific antitumor activity of radicicol oxime derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Apoptosis in dengue virus infected liver cell lines HepG2 and Hep3B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

Genetically targeted cancer therapy: tumor destruction by PKR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

New agents in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

7 January 2021

The double-stranded RNA-dependent protein kinase is also activated by heparin

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

7 January 2021

Modulation of human papillomavirus type 16 mRNA in cervical invasive carcinoma patients by interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

7 January 2021

Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.34

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.34

1 reference

16 September 2017

1 reference